Cited by 71Electrochemical sensors and biosensorsDiabetes Management and ResearchAnalytical Chemistry and Sensors

Feasibility of Continuous Long-Term Glucose Monitoring from a Subcutaneous Glucose Sensor in Humans

Gilligan, Barbara C., Shults, Mark, Rhodes, Rathbun K., Jacobs, Peter G., Brauker, James H., Pintar, Thomas J., Updike, Stuart J.·2004·Diabetes Technology & Therapeutics

Abstract

The feasibility of continuous long-term glucose monitoring in humans has not yet been demonstrated. Enzyme-based electrochemical glucose sensors with telemetric output were subcutaneously implanted and evaluated in five human subjects with type I diabetes. Subject-worn radio-receiver data-loggers stored sensor outputs. Every 1-4 weeks the subject's glucose levels were manipulated through the full clinical range of interest using standard protocols. Reference blood glucose samples were obtained every 5-10 min and analyzed in our hospital clinical laboratory and/or on glucose meters. The sensor data were evaluated versus the reference data by linear least squares regression and by the Clarke Error Grid method. After surgical explantation and device inspection, the tissue-sensor interface was evaluated histologically. The remaining sensor-membranes were also recalibrated for comparison with preimplant performance. Four of the five glucose sensors tracked glucose in vivo. One sensor responded to manipulated glucose changes for 6.2 months with clinically useful performance (>/=90% of sensor glucose values within the A and B regions of the Clarke Error Grid). For this sensor, recalibration was required every 1-4 weeks. The other three transiently responding sensors had electronic problems associated with packaging failure. The remaining sensor never tracked glucose because of failure to form any sustained connection to adjacent subcutaneous tissue. Thus, stable, clinically useful sensor performance was demonstrated in one of five subjects with diabetes for a sustained interval of greater than 6 months. While this glucose sensor implant technology shows promise in humans, it needs to be made more reliable and robust with respect to device packaging and sensor-tissue connection.

Integrity signals

Registry

Crossref · 10.1089/152091504774198089

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Long-term implanted glucose sensors in humans provided accurate readings while immobile, but posture changes led to erratic outputs.

    “For example, Gilligan et al. found that long-term implanted glucose sensors in humans provided accurate sensor readings while immobile, but posture changes (i.e., standing and/or moving) led to erratic outputs.85”
  • Four of the five sensors failed to produce analytically useful data because of electronic failure or lack of integration into the surrounding tissue.

    “However, four of the five sensors failed to produce analytically useful data due to either electronic failure or a lack of integration into the surrounding tissue.85”
  • After subcutaneous implantation in humans, one of five biosensors functioned for about 6 months, with at least 90% of measured glucose concentrations in the A and B regions of the Clarke Error Grid.

    “Following subcutaneous implantation into humans, one of five biosensors functioned for ~6 months with ≥90% of all measured glucose concentrations falling within the A and B regions of the resulting Clarke Error Grid (i.e., clinically accurate and acceptable, respectively).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Gilligan, B. C., Shults, M., Rhodes, R. K., Jacobs, P. G., Brauker, J. H., Pintar, T. J., & Updike, S. J.
Affiliations
  • University of Wisconsin–Madison (US)
  • Dexcom (United States) (US)
Venue
Diabetes Technology & Therapeutics
Published
2004-06
Volume
6
Issue
3
Pages
378-386
ISSN
  • 1520-9156 (ISSN-L)
  • 1557-8593
OpenAlex
W2174424607
Cited by
71
References
15
Citations by year
2026: 2 · 2025: 2 · 2023: 1 · 2022: 2 · 2021: 4 · 2019: 1 · 2018: 4 · 2017: 2 · 2016: 4 · 2015: 1 · 2014: 5 · 2013: 5 · 2012: 3
FWCI
3.58
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes Technology & Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Dexcom
  • National Institutes of Health
Topics
  • Physical Sciences › Engineering › Electrical and Electronic Engineering › Electrochemical sensors and biosensors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Physical Sciences › Chemical Engineering › Bioengineering › Analytical Chemistry and Sensors
Keywords
continuous glucose monitoring, subcutaneous glucose sensor, type 1 diabetes, sensor recalibration, Clarke error grid, sensor reliability, biomedical implants
MeSH terms
Adolescent, Adult, Blood Glucose, Calibration, Diabetes Mellitus, Type 1, Female, Glucose Tolerance Test, Humans, Hypoglycemic Agents, Insulin, Male, Middle Aged, Regression Analysis, Sensitivity and Specificity, Reproducibility of Results, Biosensing Techniques, Least-Squares Analysis, Monitoring, Ambulatory, Prostheses and Implants, Insulin Lispro

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review